Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.
Gombe B, Streatfield C, Leal L, Opio S, Joseph S, Weber J, Hare J, Kaleebu P, Serwanga J. Gombe B, et al. Among authors: streatfield c. PLoS One. 2022 Nov 3;17(11):e0275927. doi: 10.1371/journal.pone.0275927. eCollection 2022. PLoS One. 2022. PMID: 36327320 Free PMC article. Clinical Trial.
A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome.
Hassan AS, Hare J, Gounder K, Nazziwa J, Karlson S, Olsson L, Streatfield C, Kamali A, Karita E, Kilembe W, Price MA, Borrow P, Björkman P, Kaleebu P, Allen S, Hunter E, Ndung'u T, Gilmour J, Rowland-Jones S, Esbjörnsson J, Sanders EJ. Hassan AS, et al. Among authors: streatfield c. Clin Infect Dis. 2021 Sep 7;73(5):832-841. doi: 10.1093/cid/ciab139. Clin Infect Dis. 2021. PMID: 33588436 Free PMC article.
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.
Priddy FH, Lewis DJM, Gelderblom HC, Hassanin H, Streatfield C, LaBranche C, Hare J, Cox JH, Dally L, Bendel D, Montefiori D, Sayeed E, Ackland J, Gilmour J, Schnepp BC, Wright JF, Johnson P. Priddy FH, et al. Among authors: streatfield c. Lancet HIV. 2019 Apr;6(4):e230-e239. doi: 10.1016/S2352-3018(19)30003-7. Epub 2019 Mar 15. Lancet HIV. 2019. PMID: 30885692 Free PMC article. Clinical Trial.
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection.
Makinde J, Nduati EW, Freni-Sterrantino A, Streatfield C, Kibirige C, Dalel J, Black SL, Hayes P, Macharia G, Hare J, McGowan E, Abel B, King D, Joseph S; IAVI Protocol C Investigators; Hunter E, Sanders EJ, Price M, Gilmour J. Makinde J, et al. Among authors: streatfield c. Front Immunol. 2021 Mar 11;12:634832. doi: 10.3389/fimmu.2021.634832. eCollection 2021. Front Immunol. 2021. PMID: 33777023 Free PMC article.
Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.
Hayes P, Fernandez N, Ochsenbauer C, Dalel J, Hare J, King D, Black L, Streatfield C, Kakarla V, Macharia G, Makinde J, Price M, Hunter E; IAVI protocol C investigators; Gilmour J. Hayes P, et al. Among authors: streatfield c. PLoS One. 2021 Nov 17;16(11):e0260118. doi: 10.1371/journal.pone.0260118. eCollection 2021. PLoS One. 2021. PMID: 34788349 Free PMC article.
Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV Response.
McGowan E, Rosenthal R, Fiore-Gartland A, Macharia G, Balinda S, Kapaata A, Umviligihozo G, Muok E, Dalel J, Streatfield CL, Coutinho H, Dilernia D, Monaco DC, Morrison D, Yue L, Hunter E, Nielsen M, Gilmour J, Hare J. McGowan E, et al. Among authors: streatfield cl. Front Immunol. 2021 Feb 18;12:609884. doi: 10.3389/fimmu.2021.609884. eCollection 2021. Front Immunol. 2021. PMID: 33679745 Free PMC article.
Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial.
Cornelius V, Babalis D, Carroll WD, Cunningham S, Fleming L, Gaillard E, Gupta A, Janani L, Kennington E, Murray C, Nagakumar P, Roberts G, Seddon P, Sinha I, Streatfield C, Weir E, Saglani S. Cornelius V, et al. Among authors: streatfield c. BMJ Open. 2024 Aug 21;14(8):e090749. doi: 10.1136/bmjopen-2024-090749. BMJ Open. 2024. PMID: 39174059 Free PMC article.
15 results